EA
PGEN icon

Emerald Acquisition’s Precigen PGEN Stock Holding History

Emerald Acquisition’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$56K Sell
2,011
-12,532
-86% -$331K ﹤0.01% 2878
2016
Q2 		$355K Buy
+14,543
New +$413K ﹤0.01% 2591

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Emerald Acquisition's PGEN Position: Q3 2016 in Review

Emerald Acquisition reduced its Precigen (PGEN) stake by 86% in Q3 2016, selling an estimated $331K and leaving 2,011 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #2878.

Emerald Acquisition first reported a position in PGEN in Q2 2016 and has held it in 2 quarters since. The position peaked at $355K in Q2 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

  • Emerald Acquisition held 2,011 shares of Precigen worth $56K as of Q3 2016.
  • Emerald Acquisition sold 12,532 Precigen shares in Q3 2016, an estimated $331K.
  • Precigen made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2878 holding.
  • Emerald Acquisition first reported a position in Precigen in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Precigen position peaked at $355K in Q2 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.